Kevin Camilleri - Invictus Chief EasyDNA
Insider
Kevin Camilleri is Chief EasyDNA of Invictus MD Strategies
| Age | 47 |
| Phone | 61 3 8412 7000 |
| Web | https://genetype.com |
Invictus Management Efficiency
The company has return on total asset (ROA) of (0.6293) % which means that it has lost $0.6293 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.8498) %, meaning that it created substantial loss on money invested by shareholders. Invictus' management efficiency ratios could be used to measure how well Invictus manages its routine affairs as well as how well it operates its assets and liabilities.Invictus MD Strategies currently holds 875.19 K in liabilities with Debt to Equity (D/E) ratio of 0.04, which may suggest the company is not taking enough advantage from borrowing. Invictus MD Strategies has a current ratio of 3.78, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Invictus until it has trouble settling it off, either with new capital or with free cash flow. So, Invictus' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Invictus MD Strategies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Invictus to invest in growth at high rates of return. When we think about Invictus' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Michael McGarrity | MDxHealth SA ADR | 62 | |
| Ayman MD | Precipio | 40 | |
| Katharine Knobil | Agilent Technologies | 56 | |
| Matthew Gage | Precipio | 58 | |
| Steven Graves | Sera Prognostics | N/A | |
| Xavier MS | bioAffinity Technologies, | 55 | |
| MBA MBA | Sera Prognostics | 70 | |
| Alex Arzeno | Intelligent Bio Solutions | N/A | |
| Wim Criekinge | MDxHealth SA ADR | 52 | |
| Darlene Solomon | Agilent Technologies | 65 | |
| Keith Meadors | Precipio | N/A | |
| BBus CA | Intelligent Bio Solutions | 60 | |
| Ron Kalfus | MDxHealth SA ADR | 50 | |
| Padraig McDonnell | Agilent Technologies | 53 | |
| Maria JD | bioAffinity Technologies, | 69 | |
| Robert Harrison | Sera Prognostics | 59 | |
| Allison Ballmer | Agilent Technologies | N/A | |
| Sean MD | Sera Prognostics | N/A | |
| Susan Rataj | Agilent Technologies | 63 | |
| Otis Brawley | Agilent Technologies | 61 | |
| Mikael Dolsten | Agilent Technologies | 62 | |
Management Performance
| Return On Equity | -1.85 | |||
| Return On Asset | -0.63 |
Invictus MD Strategies Leadership Team
Elected by the shareholders, the Invictus' board of directors comprises two types of representatives: Invictus inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Invictus. The board's role is to monitor Invictus' management team and ensure that shareholders' interests are well served. Invictus' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Invictus' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kevin Camilleri, Chief EasyDNA | ||
| Mark Ziirsen, CFO Secretary | ||
| CPA BCom, Chief Secretary | ||
| Erika Spaeth, Director Affairs | ||
| AGIA BCom, CFO Sec | ||
| Bus FCI, Consultant | ||
| Simon Morriss, Chief Officer | ||
| Richard Allman, Scientific Director | ||
| Carl BSc, Chief Officer |
Invictus Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Invictus a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.85 | |||
| Return On Asset | -0.63 | |||
| Profit Margin | (1.24) % | |||
| Operating Margin | (1.13) % | |||
| Current Valuation | 3.44 M | |||
| Shares Outstanding | 4.85 M | |||
| Shares Owned By Institutions | 1.87 % | |||
| Number Of Shares Shorted | 25.84 K | |||
| Price To Earning | (1.87) X | |||
| Price To Book | 3.25 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in Invictus Stock
If you are still planning to invest in Invictus MD Strategies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Invictus' history and understand the potential risks before investing.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |